RecruitingNCT06958302

The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients


Sponsor

Ain Shams University

Enrollment

60 participants

Start Date

May 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to evaluate the relation between diabetic neuropathy in type 2 diabetes mellitus patients and muscle mass


Eligibility

Min Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This observational study is examining the link between diabetic neuropathy (nerve damage caused by diabetes) and loss of muscle mass in people with type 2 diabetes. Researchers want to know whether nerve damage accelerates muscle loss, which could have important implications for treatment and quality of life. **You may be eligible if...** - You are 45 years old or older - You have been diagnosed with type 2 diabetes - You are willing to undergo nerve testing and muscle mass measurements **You may NOT be eligible if...** - You have type 1 diabetes or gestational diabetes - You have severe heart or lung disease - You have had a prior stroke or Parkinson's disease, or other pre-existing nerve or muscle conditions that could confuse the results - You are currently taking medications known to affect nerve function Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Ain Shams university

Cairo, Abbassia, Egypt

Ain Shams university

Cairo, Abbassia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06958302


Related Trials